Literature DB >> 19304457

Family history of affective illness in schizophrenia patients: symptoms and cognition.

Deidre Anglin1, Arielle D Stanford, Jill M Harkavy-Friedman, Raymond Goetz, Paul Rosenfield, Dolores Malaspina.   

Abstract

This study examined the relationship between having a family history of affective disorder and neuropsychological functioning and PANSS symptoms in schizophrenia patients falling into four exclusive family history groups (affective spectrum disorders, schizophrenia spectrum disorders, both, or neither). Schizophrenia patients with a family history of affective illness had the best performance on IQ tests and executive function measures. Symptoms showed fewer family history group differences. Schizophrenia patients with a family history of affective disorder may be a distinct subtype in the group of schizophrenias and may be biologically more similar to patients with serious affective disorder.

Entities:  

Mesh:

Year:  2009        PMID: 19304457      PMCID: PMC2734979          DOI: 10.1016/j.schres.2009.02.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Etiological heterogeneity and intelligence test scores in patients with schizophrenia.

Authors:  Rachel Wolitzky; Nora Goudsmit; Raymond R Goetz; David Printz; Roberto Gil; Jill Harkavy-Friedman; Dolores Malaspina
Journal:  J Clin Exp Neuropsychol       Date:  2006-02       Impact factor: 2.475

2.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

Review 3.  The familial/sporadic distinction as a strategy in schizophrenia research.

Authors:  S W Lewis; A M Reveley; M A Reveley; B Chitkara; R M Murray
Journal:  Br J Psychiatry       Date:  1987-09       Impact factor: 9.319

4.  Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder.

Authors:  Elaine K Green; Rachel Raybould; Stuart Macgregor; Katherine Gordon-Smith; Jess Heron; Sally Hyde; Detelina Grozeva; Marian Hamshere; Nigel Williams; Michael J Owen; Michael C O'Donovan; Lisa Jones; Ian Jones; George Kirov; Nick Craddock
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series.

Authors:  Eiji Hattori; Chunyu Liu; Judith A Badner; Tom I Bonner; Susan L Christian; Manjula Maheshwari; Sevilla D Detera-Wadleigh; Richard A Gibbs; Elliot S Gershon
Journal:  Am J Hum Genet       Date:  2003-03-19       Impact factor: 11.025

6.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

Authors:  J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich
Journal:  Arch Gen Psychiatry       Date:  1994-11

7.  Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder.

Authors:  J Schumacher; R Abon Jamra; J Freudenberg; T Becker; S Ohlraun; A C J Otte; M Tullius; S Kovalenko; A Van Den Bogaert; W Maier; M Rietschel; P Propping; M M Nöthen; S Cichon
Journal:  Mol Psychiatry       Date:  2004-02       Impact factor: 15.992

8.  Smooth pursuit eye movement differences between familial and non-familial schizophrenia.

Authors:  B D Schwartz; B A O'Brien; W J Evans; F J Sautter; D K Winstead
Journal:  Schizophr Res       Date:  1995-10       Impact factor: 4.939

9.  Cognitive and evoked response measures of information processing in schizophrenics with and without a family history of schizophrenia.

Authors:  R F Asarnow; R L Cromwell; P M Rennick
Journal:  J Nerv Ment Dis       Date:  1978-10       Impact factor: 2.254

10.  Familial schizophrenia. A predictor of neuromotor and attentional abnormalities in schizophrenia.

Authors:  E Walker; J Shaye
Journal:  Arch Gen Psychiatry       Date:  1982-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.